LCLucila Canton

Lucila Canton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucila Canton has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Laura Moreno

    Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET, Facultad de Ciencias Veterinarias, UNCPBA. , Tandil, Argentina, Tandil, Argentina, Tandil, Argentina, Argentina

    4 shared publications
  • Carlos Lanusse

    Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET, Facultad de Ciencias Veterinarias, UNCPBA, Campus Universitario, Tandil 7000, Argentina

    3 shared publications
  • Candela Canton

    Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET, Facultad de Ciencias Veterinarias, UNCPBA, Campus Universitario, Tandil 7000, Argentina

    2 shared publications
  • Laura Ceballos

    Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET, Facultad de Ciencias Veterinarias, UNCPBA, Campus Universitario, Tandil 7000, Argentina

    2 shared publications
  • Luis Alvarez

    Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET, Facultad de Ciencias Veterinarias, UNCPBA, Campus Universitario, Tandil 7000, Argentina

    2 shared publications
  • Paula Domínguez

    Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN), CONICET, Facultad de Ciencias Veterinarias, UNCPBA, Campus Universitario, Tandil 7000, Argentina

    2 shared publications

Latest Publications

  • Open Access

    Assessment of Veterinary Antimicrobial Residues in Feedlot Soils in Argentina

    by Sergio Sánchez Bruni, Laura Galotta, María Guadalupe de Yaniz, Laureano Schofs, Mónica Sparo, Lucila Cantón, Laura Moreno, Peers Davies

    Background/Objectives: This prospective cross-sectional study quantified veterinary antimicrobial residues in soils from 27 commercial beef feedlots across multiple regions of Argentina and production scales. Methods: Using a validated Ultra-Fast Liquid Chromatography–tandem mass spectrometry (UFLC-MS/MS) method, we measured 15 target antimicrobials in pooled corral soil samples. Results: Monensin was detected in all feedlots and showed the highest detection frequency and widest concentration range; peak concentrations exceeded 15,000 ppb in some sites. Oxytetracycline presented pronounced, site-specific peaks (approaching 14,000 ppb), consistent with its strong adsorption to soil organic matter and limited biodegradation. These results indicate localised hotspots of antimicrobial loading in feedlot environments. These elevated concentrations signify substantial antimicrobial loading in confined animal environments and potential hotspots for environmental selection pressure. Compounds absent from farm treatment records were detected in 40.7% of feedlots, correlating with antimicrobial residues not matching available AMU records, including oxytetracycline, tulathromycin, cefquinome, enrofloxacin, and ciprofloxacin among others. Multiple non-exclusive explanations are plausible (historical persistence, manure redistribution, incomplete records, off-label use, or cross-contamination). The detection of critically important antimicrobials (e.g., fluoroquinolones and advanced cephalosporins) in soils raises One Health concerns about environmental selection pressure and the potential dissemination of resistance determinants. Conclusions: These findings underscore gaps in stewardship and the need for integrated environmental monitoring and improved antimicrobial usage traceability. These data provide a baseline for ecological risk assessment and resistome studies and can inform evidence-based policy and stewardship interventions in Argentine feedlot systems.

  • Open Access

    Pharmacokinetic and Pharmacodynamic Assessments of the Ivermectin and Levamisole Combination to Control Resistant Nematodes in Cattle

    by Candela Canton, Laura Ceballos, Lucila Canton, Laura Moreno, Paula Domínguez, Luis Alvarez, Carlos Lanusse

    Background/Objectives: Combination of antiparasitic drugs with different mechanisms of action has been suggested as an effective strategy to delay the development of parasite resistance. Considering the need to understand the pharmacological basis of drug combinations, the current study evaluated the potential pharmacokinetic (PK) interactions and the clinical efficacy (pharmacodynamic response) occurring after the subcutaneous administration of ivermectin (IVM) and levamisole (LEV), administered either as single treatments or concurrently to different groups of parasitized calves on three commercial farms (A, B and C). Methods: Forty-five (45) male calves naturally infected with gastrointestinal nematodes were randomly allocated into three groups (n = 15): IVM, treated with IVM by subcutaneous injection (0.2 mg/kg); LEV, treated subcutaneously with LEV (8 mg/kg); IVM + LEV, simultaneously treated with IVM and LEV (two subcutaneous injections at the same dose rates). Seven animals from each treated group (farm C) were randomly selected to perform the PK study. Drug concentrations were measured by HPLC. The therapeutic response (efficacy) was determined at 14 days after treatment by the fecal egg reduction test. Results: The mean area under the concentration vs time curve (AUC) for IVM obtained after administration of IVM alone (274 ± 65.1 ng.d/mL) was similar to that obtained when IVM was co-administered with LEV (295 ± 111 ng.d/mL). Likewise, mean LEV AUC values were similar after LEV administration alone (8.90 ± 2.69 µg.h/mL) or combined with IVM (9.11 ± 1.82 µg.h/mL). No adverse PK interactions were observed after the combined treatment, with similar PK parameters (p > 0.05) obtained between the single-drug and the combination-based strategies. On farm A, the overall fecal egg reductions were 38% (IVM), 99% (LEV) and 100% (IVM + LEV). While Cooperia spp. and Haemonchus spp. showed reduced susceptibility to IVM treatment, LEV demonstrated high efficacy against both genera, with only a minimal proportion of Haemonchus spp. remaining after treatment. Similarly, total fecal egg reductions were 42% (IVM), 99% (LEV) and 100% (IVM + LEV) on farm B, and 54% (IVM), 99% (LEV) and 100% (IVM + LEV) on farm C. On those farms, IVM was ineffective against Cooperia spp. and/or Haemonchus spp., while LEV failed to control Ostertagia spp. Remarkably, the combination of both molecules was the only treatment that achieved 100% efficacy against all nematode genera (Cooperia, Ostertagia, Haemonchus and Oesophagostomum spp.). Conclusions: Based on the described PK and pharmacodynamic (PD) assessments, the IVM + LEV combination appears to be a promising pharmacological option for controlling resistant gastrointestinal nematodes in cattle, with the additional potential to delay the progression of nematode anthelmintic resistance. Overall, the study provides original and robust pharmacokinetic and efficacy data that contribute to the optimization of parasite control strategies in cattle. This drug combination strategy may enhance treatment efficacy and contribute to improved parasite control in cattle production systems.

  • Open Access

    Pharmacokinetic and Pharmacodynamic Assessments of the Ivermectin and Levamisole Combination to Control Resistant Nematodes in Cattle

    by Canton Candela, Ceballos Laura, Canton Lucila, Moreno Laura, Dominguez María Paula, Alvarez Luis, Lanusse Carlos

    Combination of antiparasitic drugs with different mechanisms of action has been suggested as an effective strategy to delay the development of parasite resistance. Upon the need to understand the pharmacological basis of drug combinations, the current study evaluated the potential pharmacokinetic (PK) interactions and the clinical efficacy (pharmacodynamic response) occurring after the subcutaneous administration of ivermectin (IVM) and levamisole (LEV) given both separately and co-administered to parasitized calves on three commercial farms (A, B and C). Sixty (60) male calves naturally infected with gastrointestinal nematodes were randomly allocated into three groups (n= 15): IVM: treated with IVM by subcutaneous injection (0.2 mg/kg); LEV: treated subcutaneously with LEV (8 mg/kg); IVM+LEV: simultaneously treated with IVM and LEV (2 subcutaneous injections at the same dose rates). Seven (7) animals from each treated group (farm C) were randomly selected to perform the PK study. Drug concentrations were measured by HPLC. The therapeutic response (efficacy) was determined at 14 days after treatment by the fecal eggs reduction test (FECRT). The mean IVM area under the concentration vs time curve (AUC) obtained after administration of IVM alone (274 ng.d/mL) was similar to that obtained when IVM was co-administered with LEV (295 ng.d/mL). Likewise, mean LEV AUC values were similar after LEV administration alone (8.90 µg.h/mL) or combined with IVM (9.11 µg.h/mL). No adverse PK interactions were observed after the combined treatment, with similar PK parameters (P>0.05) obtained between the single-drug and the combination-based strategies. On farm A, the overall therapeutic responses (clinical efficacy) were 38% (IVM), 99% (LEV) and 100% (IVM+LEV). While the gastrointestinal nematode species Cooperia spp. and Haemonchus spp. survived the IVM treatment, Haemonchus spp. survived the LEV treatment. Similarly, total efficacies were 42% (IVM), 99% (LEV) and 100% (IVM+LEV) on farm B, and 54% (IVM), 99% (LEV) and 100% (IVM+LEV) on farm C. On those farms, IVM was ineffective against Cooperia spp. and/or Haemonchus spp., while LEV failed to control Ostertagia spp. Remarkably, the combination of both molecules was the only treatment that achieved 100% efficacy against all nematode genera (Cooperia, Ostertagia, Haemonchus and Oesophagostomum spp.). Based on the described PK-pharmacodynamic (PK-PD) assessment, the IVM+LEV combination appears to be a promising pharmacological option for controlling resistant gastrointestinal nematodes in cattle, with the additional potential to delay the progression of nematode anthelmintic resistance. Overall, the work described here contributes with sound and original pharmacology data useful to optimize parasite control in livestock. This drug combination strategy may enhance treatment efficacy while promoting more sustainable parasite management practices in cattle production systems.

  • Open Access

    Rational Pharmacotherapy in Infectious Diseases: Issues Related to Drug Residues in Edible Animal Tissues

    by Lucila Canton, Carlos Lanusse, Laura Moreno

    Drugs are used in veterinary medicine to prevent or treat animal diseases. When rationally administered to livestock following Good Veterinary Practices (GVP), they greatly contribute to improving the production of food of animal origin. Since humans can be exposed chronically to veterinary drugs through the diet, residues in food are evaluated for effects following chronic exposures. Parameters such as an acceptable daily intake (ADI), the no-observed-adverse-effect level (NOAEL), maximum residue limits (MRLs), and the withdrawal periods (WPs) are determined for each drug used in livestock. Drug residues in food exceeding the MRLs usually appear when failing the GVP application. Different factors related either to the treated animal or to the type of drug administration, and even the type of cooking can affect the level of residues in edible tissues. Residues above the MRLs can have a diverse negative impact, mainly on the consumer’s health, and favor antimicrobial resistance (AMR). Drug residue monitoring programmes are crucial to ensure that prohibited or authorized substances do not exceed MRLs. This comprehensive review article addresses different aspects of drug residues in edible tissues produced as food for human consumption and provides relevant information contributing to rational pharmacotherapy in food-producing animals.